Showing results (21-30 of 133) with videos related to
Sort By:
Pageof 14
Expert Opinion on Drug Safety|May 8, 2007
Non-chemotherapy drug-induced agranulocytosisEdeltraut GarbePharmacoepidemiology and Drug Safety|May 26, 2017
Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopeniaJuliane Bolbrinker, Edeltraut Garbe, Antonios Douros, et al.European Journal of Clinical Pharmacology|March 30, 2017
From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisionsEva Barrenberg, Edeltraut GarbeEuropean Journal of Pediatrics|February 12, 2013
Systemic antibiotic use among children and adolescents in Germany: a population-based studyJakob Holstiege, Edeltraut GarbeNature Clinical Practice. Rheumatology|November 27, 2007
Primer: administrative health databases in observational studies of drug effects--advantages and disadvantagesSamy Suissa, Edeltraut GarbeBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 21, 2015
[Benefits of large healthcare databases for drug risk research]Edeltraut Garbe, Iris PigeotJournal of Clinical Psychopharmacology|September 21, 2013
Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementiaNiklas Schmedt, Edeltraut GarbeEuropean Journal of Clinical Pharmacology|December 22, 2011
Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance StudyEdeltraut Garbe, Frank Andersohn, Elisabeth Bronder, et al.British Journal of Haematology|July 14, 2011
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance StudyEdeltraut Garbe, Frank Andersohn, Elisabeth Bronder, et al.European Journal of Clinical Pharmacology|April 1, 2011
Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case-control study in a large population-based German databaseKathrin Jobski, Sigrid Behr, Edeltraut GarbePageof 14